Literature DB >> 14675266

Appropriate cut-off value of 13C-urea breath test after eradication of Helicobacter pylori infection in Japan.

Chieko Kato1, Toshiro Sugiyama, Kunio Sato, Shinji Saito, Norihiko Kudara, Yukito Abiko, Hiroyuki Sasaki, Toshimi Chiba, Kimihiko Satoh, Takashi Akihama, Kazuyuki Suzuki.   

Abstract

BACKGROUND AND AIM: A cut-off value of 2.5 per thousand for the 13C-urea breath test (UBT) is recommended in Japanese persons, based on the result of a multicenter trial in patients prior to treatment for eradication of Helicobacter pylori. The cut-off value of 2.5 per thousand has also been used in the assessment of eradication after treatment. The 6-8-week evaluation after treatment is recommended in the guidelines of the Japanese Society of Gastroenterology. The present study aimed to prospectively re-assess the cut-off value of the 13C-UBT at 6 weeks after treatment by using the results obtained at 6 months as an indication of true positive or true negative H. pylori infection status.
METHODS: One hundred and ninety patients who were positive for H. pylori underwent eradication treatment, and 177 patients of these patients who were assessed as having true positive or true negative H. pylori status at 6 months after treatment were evaluated in this study. Eradication was assessed by 13C-UBT, culture, and histology at 6 weeks and at 6 months after treatment, and the cut-off value of 13C-UBT at 6 weeks was re-assessed.
RESULTS: A cut-off value of 3.5 per thousand. at 6 weeks after treatment showed 97.2% diagnostic accuracy, while a cut-off value of 2.5 per thousand at 6 weeks showed 96.0% diagnostic accuracy. For a 3.5 per thousand cut-off value, only five patients were positive by 13C-UBT and were negative by culture and histology at 6 weeks, and three patients were true positive and two were false positive by the 13C-UBT at 6 months.
CONCLUSION: A cut-off value of 3.5 per thousand for the 13C-UBT is recommended at 6 weeks after eradication treatment in Japanese persons.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14675266     DOI: 10.1046/j.1440-1746.2003.03193.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  10 in total

1.  13C urea breath test for (Helicobacter pylori): determination of the optimal cut-off point in a Canadian community population.

Authors:  Marina Mauro; Vladimir Radovic; Pengfei Zhou; Melanie Wolfe; Markad Kamath; Premsyl Bercik; Ken Croitoru; David Armstrong
Journal:  Can J Gastroenterol       Date:  2006-12       Impact factor: 3.522

2.  Applicability of a rapid stool antigen test, using monoclonal antibody to catalase, for the management of Helicobacter pylori infection.

Authors:  Tadashi Shimoyama; Manabu Sawaya; Atsushi Ishiguro; Norihiro Hanabata; Tetsuro Yoshimura; Shinsaku Fukuda
Journal:  J Gastroenterol       Date:  2011-01-25       Impact factor: 7.527

Review 3.  Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits.

Authors:  David Y Graham
Journal:  Gastroenterology       Date:  2015-02-02       Impact factor: 22.682

4.  Comparison of a monoclonal with a polyclonal antibody-based enzyme immunoassay stool test in diagnosing Helicobacter pylori infection after eradication therapy.

Authors:  Ryuzo Deguchi; Masashi Matsushima; Takayoshi Suzuki; Tetsuya Mine; Ryuki Fukuda; Makoto Nishina; Hideki Ozawa; Atsushi Takagi
Journal:  J Gastroenterol       Date:  2009-05-21       Impact factor: 7.527

5.  Optimization of 13 C-urea breath test threshold levels for the detection of Helicobacter pylori infection in a national referral laboratory.

Authors:  Tsachi Tsadok Perets; Rachel Gingold-Belfer; Haim Leibovitzh; David Itskoviz; Hemda Schmilovitz-Weiss; Yifat Snir; Ram Dickman; Iris Dotan; Zohar Levi; Doron Boltin
Journal:  J Clin Lab Anal       Date:  2018-09-17       Impact factor: 2.352

6.  Cut-off optimization for 13C-urea breath test in a community-based trial by mathematic, histology and serology approach.

Authors:  Zhe-Xuan Li; Lei-Lei Huang; Cong Liu; Luca Formichella; Yang Zhang; Yu-Mei Wang; Lian Zhang; Jun-Ling Ma; Wei-Dong Liu; Kurt Ulm; Jian-Xi Wang; Lei Zhang; Monther Bajbouj; Ming Li; Michael Vieth; Michael Quante; Tong Zhou; Le-Hua Wang; Stepan Suchanek; Erwin Soutschek; Roland Schmid; Meinhard Classen; Wei-Cheng You; Markus Gerhard; Kai-Feng Pan
Journal:  Sci Rep       Date:  2017-05-18       Impact factor: 4.379

7.  Correlation between Quantitative 13C-Urea Breath Test and Helicobacter pylori Treatment Success in a Population-Based Cohort.

Authors:  Doron Boltin; Zohar Levi; Tsachi Tsadok Perets; Hemda Schmilovitz-Weiss; Rachel Gingold-Belfer; Ram Dickman; Iris Dotan
Journal:  Gastroenterol Res Pract       Date:  2018-11-13       Impact factor: 2.260

8.  Short-term outcomes and intermediate-term follow-up of Helicobacter pylori infection treatment for naïve patients: a retrospective observational study.

Authors:  Yujing Wang; Yu Xiang; Oulan Liao; Yaoyi Wu; Yan Li; Qin Du; Jun Ye
Journal:  BMJ Open       Date:  2022-09-17       Impact factor: 3.006

Review 9.  Non-invasive diagnostic tests for Helicobacter pylori infection.

Authors:  Lawrence Mj Best; Yemisi Takwoingi; Sulman Siddique; Abiram Selladurai; Akash Gandhi; Benjamin Low; Mohammad Yaghoobi; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15

10.  Randomized Trial Comparing Esomeprazole and Rabeprazole in First-line Eradication Therapy for Helicobacter pylori Infection based on the Serum Levels of Pepsinogens.

Authors:  Tadashi Shimoyama; Daisuke Chinda; Yoshihiko Sawada; Kazuo Komai; Hironobu Chiba; Yoshiharu Saito; Yoshio Sasaki; Masashi Matsuzaka; Shinsaku Fukuda
Journal:  Intern Med       Date:  2017-07-01       Impact factor: 1.271

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.